Operations Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


OPERATIONS RESEARCH
Vol. 53, No. 3, May-June 2005, pp. 456-476
DOI: 10.1287/opre.1040.0143
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J. T.
Right arrow Articles by Perelson, A. S.
Right arrow Search for Related Content

Optimization of Influenza Vaccine Selection

Joseph T. Wu, Lawrence M. Wein, Alan S. Perelson

Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, and Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332
Graduate School of Business, Stanford University, Stanford, California 94305
Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico 87545

joewu{at}isye.gatech.edu
lwein{at}stanford.edu
asp{at}lanl.gov

The World Health Organization (WHO) recommends which strains of influenza to include in each year’s vaccine to countries around the globe. The current WHO strategy attempts to match the vaccine strains with the expected upcoming epidemic strains, a strategy we refer to as the follow policy. The recently proposed antigenic distance hypothesis suggests that vaccine efficacy can be enhanced by taking into account the antigenic histories of vaccinees. To assess the potential benefit of history-based vaccination, we formulate the annual vaccine-strains selection problem as a stochastic dynamic program using the theory of shape space, which maps each vaccine and epidemic strain into a point in multidimensional space. Computational results show that a near-optimal policy can be derived by approximating the entire antigenic history by a single reduced historical strain, and then solving the multiperiod problem myopically, as a series of single-period problems. The modest suboptimality of the follow policy, together with our current inability to quantitatively link the model’s objective function (a measure of cross-reactivity) with actual vaccine efficacy, leads us to recommend the continued use of the follow policy.

Subject classifications: dynamic programming; health care.
History: Received October 2003; revision received February 2004; accepted April 2004.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by INFORMS.